ZIM Laboratories Limited

NSEI:ZIMLAB Stock Report

Market Cap: ₹5.2b

ZIM Laboratories Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for ZIM Laboratories.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth17.8%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

No updates

Recent updates

ZIM Laboratories (NSE:ZIMLAB) Has A Somewhat Strained Balance Sheet

Nov 14
ZIM Laboratories (NSE:ZIMLAB) Has A Somewhat Strained Balance Sheet

ZIM Laboratories' (NSE:ZIMLAB) Anemic Earnings Might Be Worse Than You Think

May 21
ZIM Laboratories' (NSE:ZIMLAB) Anemic Earnings Might Be Worse Than You Think

Earnings Not Telling The Story For ZIM Laboratories Limited (NSE:ZIMLAB) After Shares Rise 28%

Apr 26
Earnings Not Telling The Story For ZIM Laboratories Limited (NSE:ZIMLAB) After Shares Rise 28%

ZIM Laboratories Limited's (NSE:ZIMLAB) Shares May Have Run Too Fast Too Soon

Feb 20
ZIM Laboratories Limited's (NSE:ZIMLAB) Shares May Have Run Too Fast Too Soon

Estimating The Fair Value Of ZIM Laboratories Limited (NSE:ZIMLAB)

May 16
Estimating The Fair Value Of ZIM Laboratories Limited (NSE:ZIMLAB)

Sentiment Still Eluding ZIM Laboratories Limited (NSE:ZIMLAB)

Nov 29
Sentiment Still Eluding ZIM Laboratories Limited (NSE:ZIMLAB)

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as ZIM Laboratories has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

NSEI:ZIMLAB - Analysts future estimates and past financials data (INR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
9/30/20243,882162-362299N/A
6/30/20243,819179N/AN/AN/A
3/31/20243,675172-576163N/A
12/31/20233,551164N/AN/AN/A
9/30/20233,597182-34524N/A
6/30/20233,733195N/AN/AN/A
3/31/20233,98624415382N/A
12/31/20223,983242N/AN/AN/A
9/30/20223,840217335550N/A
6/30/20223,620195N/AN/AN/A
3/31/20223,335146340492N/A
12/31/20213,02391N/AN/AN/A
9/30/20212,9056335156N/A
6/30/20213,01042N/AN/AN/A
3/31/20213,07373254319N/A
12/31/20203,02781N/AN/AN/A
9/30/20203,01183264355N/A
6/30/20202,80865N/AN/AN/A
3/31/20202,7783334219N/A
12/31/20193,03233N/AN/AN/A
9/30/20193,2797791295N/A
6/30/20193,317116N/AN/AN/A
3/31/20193,354153146349N/A
12/31/20183,123208N/AN/AN/A
9/30/20182,894212N/AN/AN/A
6/30/20182,804208N/AN/AN/A
3/31/20182,729191N/A367N/A
3/31/20172,350186N/A321N/A
3/31/20162,68551N/A219N/A
3/31/20152,663-216N/A71N/A
3/31/20142,271101N/A33N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if ZIMLAB's forecast earnings growth is above the savings rate (6.7%).

Earnings vs Market: Insufficient data to determine if ZIMLAB's earnings are forecast to grow faster than the Indian market

High Growth Earnings: Insufficient data to determine if ZIMLAB's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if ZIMLAB's revenue is forecast to grow faster than the Indian market.

High Growth Revenue: Insufficient data to determine if ZIMLAB's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if ZIMLAB's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y